Bvf Inc Mirum Pharmaceuticals, Inc. Call Options Transaction History
Bvf Inc
- $2.28 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MIRM
# of Institutions
224Shares Held
55.4MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$298 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$209 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$142 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$111 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.53MShares$111 Million2.42% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.61B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...